Clinical Scorecard: Examining the Link Between the Triglyceride-Glucose Index and Diabetic Peripheral Neuropathy: A Comprehensive Review and Meta-Analysis
At a Glance
Category
Detail
Condition
Diabetic Peripheral Neuropathy (DPN)
Key Mechanisms
Insulin resistance and metabolic disturbances leading to nerve injury.
Target Population
Patients with type 2 diabetes mellitus (T2DM).
Care Setting
Clinical practice for diabetes management.
Key Highlights
DPN occurs in approximately 30% of individuals with T2DM.
Higher triglyceride-glucose (TyG) index values correlate with increased DPN risk.
Pooled odds ratio for DPN risk associated with elevated TyG index is 2.614.
DPN is linked to significant economic burden and reduced quality of life.
Early screening for DPN is critical to slow disease progression.
Guideline-Based Recommendations
Diagnosis
DPN is diagnosed clinically through nerve conduction studies and electromyography.
Management
Timely risk screening and warning are essential to decelerate disease progression.
Monitoring & Follow-up
Evaluate insulin resistance status to identify early DPN risk.
Risks
DPN is associated with increased all-cause and cardiovascular mortality.
Patient & Prescribing Data
Patients with type 2 diabetes mellitus (T2DM).
Higher TyG index values indicate greater risk for DPN.
Clinical Best Practices
Implement early screening for DPN using accessible and sensitive biomarkers.
Consider metabolic disturbances as central drivers in DPN pathogenesis.
